BiOkuris’ latest paper : « Chitin-glucan improves important pathophysiological features of IBS »
Le dernier article de BiOkuris, intitulé "Chitin-glucan improves important pathophysiological features of IBS", a été accepté et publié dans le réputé "World Journal of Gastroenterology".
BiOkuris’ latest paper, titled « Chitin-glucan improves important pathophysiological features of IBS, » has been accepted and published in the esteemed « World Journal of Gastroenterology. » This groundbreaking study unravels the intricate mechanisms by which Chitin-Glucan (CG) addresses the key pathophysiological aspects of Irritable Bowel Syndrome (IBS), including visceral analgesia, intestinal inflammation, gut barrier function, and toxin chelation.